Steven St. Peter
2014
In 2014, Steven St. Peter earned a total compensation of $7.9M as President and CEO at Aratana Therapeutics, a 571% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $222,063 |
|---|---|
| Option Awards | $3,027,719 |
| Salary | $467,500 |
| Stock Awards | $4,144,500 |
| Other | $10,400 |
| Total | $7,872,182 |
Peter received $4.1M in stock awards, accounting for 53% of the total pay in 2014.
Peter also received $222.1K in non-equity incentive plan, $3M in option awards, $467.5K in salary and $10.4K in other compensation.
Rankings
In 2014, Steven St. Peter's compensation ranked 792nd out of 13,032 executives tracked by ExecPay. In other words, Peter earned more than 93.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 792 out of 13,032 | 94th |
Division Manufacturing | 287 out of 4,965 | 94th |
Major group Chemicals And Allied Products | 95 out of 1,690 | 94th |
Industry group Drugs | 74 out of 1,369 | 95th |
Industry Pharmaceutical Preparations | 68 out of 1,042 | 94th |
Source: SEC filing on April 28, 2015.
Peter's colleagues
We found four more compensation records of executives who worked with Steven St. Peter at Aratana Therapeutics in 2014.